MetaCap

Lycia Therapeutics SEC Filings

NASDAQ: LYCAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

33.07+1.30 (+4.09%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Lycia Therapeutics filing overview

This page lists 17 recent SEC filings by Lycia Therapeutics (LYCA), including 12 4, 1 SCHEDULE 13G, 1 8-K, 1 424B4. The latest current report (8-K), used to disclose material events such as earnings releases and executive changes, was filed on Oct 26, 2026. Form 10-K is the audited annual report, 10-Q the quarterly report, 8-K covers material events, and Form 4 reports insider transactions. All documents link directly to SEC EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

LYCA SEC filings

Lycia Therapeutics SEC filings
FiledFormDescriptionDocument
Nov 4, 20264Statement of changes in beneficial ownershipView on EDGAR
Oct 30, 20264Statement of changes in beneficial ownershipView on EDGAR
Oct 30, 2026SCHEDULE 13GBeneficial ownership report (passive)View on EDGAR
Oct 28, 20264Statement of changes in beneficial ownershipView on EDGAR
Oct 27, 20264Statement of changes in beneficial ownershipView on EDGAR
Oct 26, 20264Statement of changes in beneficial ownershipView on EDGAR
Oct 26, 20264Statement of changes in beneficial ownershipView on EDGAR
Oct 26, 20264Statement of changes in beneficial ownershipView on EDGAR
Oct 26, 20268-KAmendments to Articles of Incorporation or Bylaws; Change in Fiscal YearView on EDGAR
Oct 26, 20264Statement of changes in beneficial ownershipView on EDGAR
Oct 26, 20264Statement of changes in beneficial ownershipView on EDGAR
Oct 26, 20264Statement of changes in beneficial ownershipView on EDGAR
Oct 26, 20264Statement of changes in beneficial ownershipView on EDGAR
Oct 26, 20264Statement of changes in beneficial ownershipView on EDGAR
Oct 23, 2026424B4ProspectusView on EDGAR
Oct 20, 2026S-1/ARegistration statement (amendment)View on EDGAR
Oct 5, 2026S-1DRS/AView on EDGAR

Related